Fauci says Pfizer coronavirus vaccine likely available for high-risk cases by December
Dr. Anthony Fauci, the U.S. government's top infectious disease expert, said that a coronavirus vaccine could be available for the nation's highest-risk individuals as soon as December.
Dr. Anthony Fauci, the U.S. government's top infectious disease expert, said that a coronavirus vaccine could be available for the nation's highest-risk individuals as soon as December.
COVID-19 vaccine timeline: A look at what’s ahead for leading candidates
Pfizer and the makers of the other leading U.S. COVID-19 vaccine candidates have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late November.
Pfizer and the makers of the other leading U.S. COVID-19 vaccine candidates have been cautioning for weeks that the earliest they could seek regulatory approval for wider use of their shots would be late November.
200+ Austinites have been a part of Pfizer vaccine trials
Since August, ARC has enrolled more than 200 adult patients in the trials.
Since August, ARC has enrolled more than 200 adult patients in the trials.
Pfizer says early data signals COVID-19 vaccine is 90% effective
Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.
Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.
COVID-19 vaccine: Who will get the first doses?
Scientists vary in their recommendations over who should get the first doses of the COVID-19 vaccine.
Scientists vary in their recommendations over who should get the first doses of the COVID-19 vaccine.
AstraZeneca plans to deliver vaccine trial data by year's end
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
Austin Regional Clinic accepting kids 12-17 for COVID-19 vaccine trials
The trial will consist of phases, just like the adult trials, with the kids getting two shots and doing a follow-up months later.
The trial will consist of phases, just like the adult trials, with the kids getting two shots and doing a follow-up months later.
ARC Clinical Research enrolling children for COVID-19 vaccine trial
ARC Clinical Research, Austin Regional Clinic’s medical research department that enables clinical trials, has announced that it's looking to enroll children 12-17 years old in Pfizer’s COVID-19 vaccine clinical trial.
ARC Clinical Research, Austin Regional Clinic’s medical research department that enables clinical trials, has announced that it's looking to enroll children 12-17 years old in Pfizer’s COVID-19 vaccine clinical trial.
Fauci estimates COVID-19 vaccine won’t be available until January 2021 or later
The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.
The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.
FDA allows AstraZeneca’s COVID-19 vaccine trial to resume in US
The late-stage trial of a leading COVID-19 vaccine candidate from AstraZeneca and the University of Oxford will resume in the U.S., according to a report from the Wall Street Journal.
The late-stage trial of a leading COVID-19 vaccine candidate from AstraZeneca and the University of Oxford will resume in the U.S., according to a report from the Wall Street Journal.
Volunteer in AstraZeneca coronavirus clinical trial dies, report says
The volunteer was a man in his 20s, according to reports. It was not immediately clear if the man received the vaccine or had been part of a placebo group.
The volunteer was a man in his 20s, according to reports. It was not immediately clear if the man received the vaccine or had been part of a placebo group.
Pfizer to start testing COVID-19 vaccine in kids
Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children.
Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children.
Vaccines will be limited in supply and logistically challenging to distribute at first in California
"Don't expect you can go down the pharmacy during this calendar year and get a vaccine," Gov. Gavin Newsom said. "It is simply unrealistic. We don't anticipate mass availability until 2021."
"Don't expect you can go down the pharmacy during this calendar year and get a vaccine," Gov. Gavin Newsom said. "It is simply unrealistic. We don't anticipate mass availability until 2021."
Federal health officials planning to get coronavirus shots to nursing homes
The nation has 15,000-16,000 nursing homes, according to the Centers for Disease Control and Prevention. There may be another 20,000-45,000 assisted living facilities and similar kinds of settings for elderly and disabled people.
The nation has 15,000-16,000 nursing homes, according to the Centers for Disease Control and Prevention. There may be another 20,000-45,000 assisted living facilities and similar kinds of settings for elderly and disabled people.
Trump announces CVS, Walgreens free coronavirus vaccines deal to help seniors
Residents in all types of long-term care facilities will be able to access the vaccine at no charge
Residents in all types of long-term care facilities will be able to access the vaccine at no charge
FOX 7 Discussion: Will Texans get a COVID-19 vaccine?
Glenn Smith with Progress Texas and Travis County GOP chairman Matt Mackowiak join Rebecca Thomas on FOX 7 Austin to talk about a recent poll concerning a potential COVID-19 vaccine.
Glenn Smith with Progress Texas and Travis County GOP chairman Matt Mackowiak join Rebecca Thomas on FOX 7 Austin to talk about a recent poll concerning a potential COVID-19 vaccine.
Eli Lilly pauses COVID-19 antibody drug trial over potential safety concerns
The Eli Lilly drug is similar to one that President Donald Trump received from Regeneron Pharmaceuticals.
The Eli Lilly drug is similar to one that President Donald Trump received from Regeneron Pharmaceuticals.
Johnson & Johnson pauses COVID-19 vaccine trial over 'unexplained illness'
Drug-maker Johnson & Johnson says it is temporarily pausing clinical trials of a COVID-19 vaccine due to "an unexplained illness in a study participant."
Drug-maker Johnson & Johnson says it is temporarily pausing clinical trials of a COVID-19 vaccine due to "an unexplained illness in a study participant."
Johnson & Johnson vaccine trial paused over unexplained illness
A late-stage study of Johnson & Johnson's COVID-19 vaccine candidate has been paused while the company investigates whether a study participant's "unexplained illness" is related to the shot.
A late-stage study of Johnson & Johnson's COVID-19 vaccine candidate has been paused while the company investigates whether a study participant's "unexplained illness" is related to the shot.
2nd coronavirus vaccine trial paused over unexplained illness
The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.
The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.